Description
Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide also acts as a voltage-dependent sodium and calcium channel blocker.
Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide also acts as a voltage-dependent sodium and calcium channel blocker.
Alternate Name/Synonyms: (S)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propenamide; FCE-26743 ; EMD-1195686,
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 133865-89-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₇H₁₉FN₂O₂
Molecular Weight: 302.35
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor
MDL Number: MFCD00897036
PubChem CID: 131682
SMILES: CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F
InChi: InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1
InChi Key: NEMGRZFTLSKBAP-LBPRGKRZSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |